The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma

Thiel, Johannes Tobias; Daigeler, Adrien; Kolbenschlag, Jonas; Rachunek, Katarzyna; Hoffmann, Sebastian

dc.contributor.author	Thiel, Johannes Tobias
dc.contributor.author	Daigeler, Adrien
dc.contributor.author	Kolbenschlag, Jonas
dc.contributor.author	Rachunek, Katarzyna
dc.contributor.author	Hoffmann, Sebastian
dc.date.accessioned	2023-06-19T09:35:12Z
dc.date.available	2023-06-19T09:35:12Z
dc.date.issued	2022
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/142274
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers14143380	de_DE
dc.subject.ddc	610	de_DE
dc.title	The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_02478
utue.personen.roh	Thiel, Johannes Tobias
utue.personen.roh	Daigeler, Adrien
utue.personen.roh	Kolbenschlag, Jonas
utue.personen.roh	Rachunek, Katarzyna
utue.personen.roh	Hoffmann, Sebastian
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 3380	de_DE
dcterms.isPartOf.ZS-Volume	14 (14)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE